Rankings
▼
Calendar
BOLD Q4 2022 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena
BOLD
Boundless Bio, Inc.
$26M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$12M
Net Income
-$12M
EPS (Diluted)
$-0.53
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$592,000
Balance Sheet
Total Assets
$77M
Total Liabilities
$159M
Stockholders' Equity
-$82M
Cash & Equivalents
$11M
← FY 2022
All Quarters
Q1 2023 →